Leader's Corner

Dr. Tom Lynch, President and Director, Fred Hutch
Dr. Tom Lynch

From Our President and Director

Dr. Thomas J. Lynch Jr. is a world-renowned scientist, highly respected oncologist and successful leader of National Cancer Institute-Designated Comprehensive Cancer Centers. Dr. Lynch sets the strategic direction of the center, oversees centerwide initiatives and represents Fred Hutch’s interests to major partners and governmental bodies. He also directs the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium and is principal investigator of its Cancer Center Support Grant.
Read more about Dr. Lynch.  

Upcoming Events

Mar 27
Mar 27

Obliteride Team Captain Kickoff

5:30 - 7:30 p.m.
Join us at a special event for anyone thinking about starting or bringing back an Obliteride team! You’ll hear from fellow team captains about how to build, inspire, and lead a successful team; talk with the researchers they support about how important our fundraising is for world-changing discoveries; go behind-the-scenes on a lab tour; and get important information on Obliteride 2025. All while enjoying snacks and beverages!
Location Fred Hutch Cancer Center, Arnold Building Atrium
Host Fred Hutch Obliteride
Aug 9
Aug 9

Obliteride

Fred Hutch Obliteride is a bike ride and 5K walk/run that connects and empowers people to help cure cancer faster by raising funds for Fred Hutch Cancer Center. Ride your bike 25, 50, or 100 miles, walk or run a 5K, volunteer, or choose your own adventure and participate virtually!
Host Fred Hutch

Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.

Recent Posts

More From Leadership
Dr. Anthony Fauci to receive honorary Hutch Award® Director of the National Institute of Allergy and Infectious Diseases recognized for his lifetime of service to a healthier world August 4, 2022
Making immunotherapy more effective against small cell lung cancer Human trial opens after experimental drug improves tumor growth suppression in mice August 3, 2022
Blood and Marrow Transplant Reunion returns to Fred Hutch Hundreds gather in Seattle to celebrate life, science and cancer survivorship July 19, 2022
Hutch scientists receive $25M to solve breast cancer metastasis New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread July 28, 2022

Fred Hutch President and Director Dr. Tom Lynch shares partnerships in 2021 that fueled important new scientific strides — and what we see in 2022.

Featured Videos

Take a look behind the scenes in the Kugel Lab at Fred Hutch, where researchers are exploring new ways to treat an aggressive subtype of pancreatic cancer.

Take a look behind the scenes of the Chapuis Lab at Fred Hutch.

President & Director and holder of the Raisbeck Endowed Chair Dr. Tom Lynch visits the lab of Dr. Meghan Koch in Fred Hutch's Basic Sciences Division, where researchers looks to answer fundamental questions about the development of the immune system.

Fred Hutch Director and President Dr. Thomas Lynch Jr. visits the Newell Lab to see how immunotherapy research and data science come together in the Steam Plant.

Fred Hutch President & Director Dr. Thomas J. Lynch Jr. visits the Berger Lab to meet the staff and see what the lab is working on.

The Fred Hutchinson Cancer Center opening day event on April 1, 2022, featuring remarks from Fred Hutch President and Director Dr. Thomas J. Lynch Jr., board chair Kathy Surace-Smith, UW Medicine CEO Dr. Paul Ramsey, Fred Hutch Executive Vice President and Deputy Director Dr. Bruce Clurman, and Fred Hutch Chief Nursing Officer Dr. Terry McDonnell.

Fred Hutch President and Director Dr. Tom Lynch shares partnerships in 2021 that fueled important new scientific strides — and what we see in 2022.

Dr. Tom Lynch spoke with Drs. Alice Berger, Lucas Sullivan and Christopher Li at Fred Hutch's Science Says virtual event on May 25, 2022, about how emerging technologies and a growing volume and variety of molecular data are allowing scientists to create personalized cancer therapies and prevention strategies.

Dr. Tom Lynch tours the Emerman Lab with Dr. Emerman — learns more hear about the efforts to find insights into effective cellular antiviral defenses could also shed light on avenues for development of potential future antiretroviral therapies for HIV and COVID.

How Fred Hutch is facing the next era of cancer research, patient care

In a Q&A, Dr. Thomas Lynch addressed oncology workforce changes: “Yes, it's got high pressure, it's got the same kind of burnout issues that so much of society has now. But oncology is special, particularly because of how the profession evolves.”

Becker’s Hospital Review
February 26, 2025

Can AI cure cancer? New alliance unites tech giants and big research orgs in quest for breakthroughs

Dr. Thomas Lynch discussed the newly formed Cancer AI Alliance: “What was interesting about this whole process was how we were able to bring together these four incredible cancer centers, and these four major tech companies.”

GeekWire
October 02, 2024

They’re Here To Save Your Life

Seattle Magazine featured Fred Hutch scientists Drs. Phil Greenberg, Denise Galloway, E. Gabriela Chiorean and Petros Grivas in an article about doctors who continue to make Seattle a hotbed of cancer research and treatment.

Seattle Magazine
June 20, 2022

Can these drugs stop a COVID infection in its tracks? Seattle researchers are on the forefront of new treatments

Dr. Liz Duke explained a study of antivirals to prevent COVID.

Seattle Times
June 13, 2022

‘The future of cancer care’: Seattle institutions connect research, clinics under Fred Hutch name

Drs. Tom Lynch and Paul Ramsey describe unified adult cancer care.

GeekWire
April 02, 2022

Your search for "" did not match any items. Please try another term or combination of terms and filters.